MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-19-0027888
Galentic Pharma India Pvt Ltd - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹195.24 Cr
▲ 56% YoY
Net profit · FY 2025
₹46.42 Cr
Net margin 23.8%
EBITDA · FY 2025
₹64.63 Cr
EBITDA margin 33.1%
Authorised capital
₹45 Lakh
Registered with MCA
Paid-up capital
₹13.42 Lakh
Issued & subscribed
Open charges
₹131.07 Cr
Satisfied ₹1.27 Cr
Company age
34 yrs
Est. 1992
Employees · EPFO
294
Provident fund records
About Galentic Pharma India Pvt Ltd
Data last updated:
Galentic Pharma India Pvt Ltd is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 March 1992 and has been in existence for over 34 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1992PTC065825. Its GSTIN is 27AAACG2390L1ZG (Maharashtra). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹45 Lakh and a paid-up capital of ₹13.42 Lakh. It is led by directors including Bhupendra Harkisandas Sangani (Managing Director) and Smita Bhupendra Sangani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 4th Floor Samruddhi Venture Park MIDC Central Road Marol Andheri(East), Mumbai, Maharashtra, India – 400093.
As per the financials filed for FY 2025, the company reported a revenue of ₹195.24 Cr, a growth of 56% compared to the previous year. For the same year it recorded a net profit of ₹46.42 Cr (net margin 23.8%) and EBITDA of ₹64.63 Cr (EBITDA margin 33.1%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 14% over five years.
The company has about 294 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Galentic Pharma. As per MCA filings, the company has open charges of ₹131.07 Cr and satisfied charges of ₹1.27 Cr on record. Court records list 5 cases involving the company, including 1 filed by the company and 4 filed against it; 4 cases are pending.
Galentic Pharma India Pvt Ltd is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0027888). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website galentic.com.
Company details
CIN U24230MH1992PTC065825
Registration Number 065825
Incorporation Date 10 March 1992
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-19-0027888
Key People
Bhupendra Harkisandas Sangani Managing Director Smita Bhupendra Sangani Director Amisha Maulin Gandhi Director Recognitions & Rankings of Galentic Pharma India
Contact details
Galentic Pharma India Pvt Ltd's registered office is in Mumbai, Maharashtra. Its website is galentic.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address4th Floor Samruddhi Venture Park MIDC Central Road Marol Andheri(East), Mumbai, Maharashtra, India – 400093
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Galentic Pharma India Pvt Ltd, buy the company report.
Comprehensive company report
Galentic Pharma India Pvt Ltd - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Galentic Pharma India operates one associated brand: Galentic Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures sterile ophthalmic and non-sterile dermatological products for affordable healthcare worldwide. | galentic.com |
Business activity
The main business activity of Galentic Pharma India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Galentic Pharma India Pvt Ltd, buy the company report.
Financials of Galentic Pharma India Pvt Ltd
FY 2025 filings availableGalentic Pharma India Pvt Ltd reported revenue of ₹195.24 Cr (up 56% YoY) for FY 2025.
Revenue · FY 2025
₹195.24 Cr ▲ 56%
Net profit · FY 2025
₹46.42 Cr margin 23.8%
EBITDA · FY 2025
₹64.63 Cr margin 33.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 56%
3 years · compounded
▲ 15%
5 years · compounded
▲ 14%
EBITDA CAGR growth
1 year
▲ 151%
3 years · compounded
▲ 21%
5 years · compounded
▲ 15%
Revenue has grown at a compounded annual rate (CAGR) of 14% over five years, including 56% growth in the latest year. EBITDA rose 151% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹64.63 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹46.42 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 33.1% | ||||
| Net Profit Margin | 23.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Galentic Pharma India Pvt Ltd, buy the company report.
Board of directors of Galentic Pharma India Pvt Ltd
Galentic Pharma India has 7 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Smita Bhupendra Sangani | Director | 18 Mar 2013 | 13 Years 7 Months | Current |
| Amisha Maulin Gandhi | Director | 28 Sep 2021 | 5 Years 0 Months | Current |
| Bhupendra Harkisandas Sangani Also directs: The Ethical Pharmaceutical Co. Private Limited | Managing Director | 03 Jan 1994 | 32 Years 9 Months | Current |
| Manthan Kamlesh Vohra Also directs: Enka Business Technologies LLP | Director | 28 Sep 2021 | 5 Years 0 Months | Current |
| Jay Narendra Mehta Also directs: Anekanta Ventures LLP, Shree Vardhaman Chemicals Private Limited, Mehta Properties Private Limited and 1 more | Director | 28 Sep 2021 | 5 Years 0 Months | Current |
| Hemang Kamlesh Vohra Also directs: Apollo Business Technologies Private Limited | Director | 18 Mar 2013 | 13 Years 7 Months | Current |
Showing 6 of 7 current directors. View all directors
Peer comparison
Galentic Pharma India Pvt Ltd is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Alphamed Formulations Private Limited | ₹196.73 Cr (FY 2025) | 22.0% | Shamirpet, Telangana, India | |||
| Jagdale Industries Private Limited | ₹195.3 Cr (FY 2025) | 3.0% | Bangalore, Karnataka, India | |||
| Galentic Pharma India Pvt Ltdthis company | ₹195.24 Cr (FY 2025) | ₹46.42 Cr | 23.8% | 56.0% | 294 | Mumbai, Maharashtra, India |
| Therachem Research Medilab (India) Private Limited | ₹194.12 Cr (FY 2023) | -7.0% | Jaipur, Rajasthan, India | |||
| Sriram Healthcare Private Limited | ₹192.28 Cr (FY 2025) | -8.0% | Kasauli, Himachal Pradesh, India | |||
| Parnax Lab Limited | ₹189.41 Cr (FY 2025) | 0.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Galentic Pharma India Pvt Ltd, buy the company report.
Auditor
Galentic Pharma India Pvt Ltd is audited by Mehta Chokshi & Shah Llp for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Mehta Chokshi & Shah Llp | FY 2024 | 106201W/W100598 |
Shareholding
The shareholding of Galentic Pharma India Pvt Ltd is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Galentic Pharma India Pvt Ltd, buy the company report.
Charges & borrowings
Open charges
₹131.07 Cr
Satisfied charges
₹1.27 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Apr 2025 | 101100210 | Hdfc Bank Limited | ₹32.4 Lakh | Open | |
| 25 Feb 2022 | 100546148 | Citi Bank N.A. | ₹7.2 Cr | Open | |
| 21 Jan 2022 | 100527285 | Citi Bank N.A. | ₹15 Cr | Open | |
| 11 Oct 2013 | 10454464 | Hdfc Bank Limited | ₹11 Cr | Open | |
| 30 Sep 2013 | 10454461 | Hdfc Bank Limited | ₹68.2 Cr | Open |
To see the full charge records of Galentic Pharma India Pvt Ltd, buy the company report.
Total charge records: 8 View all charges
Legal cases
Galentic Pharma India Pvt Ltd has 5 court cases on record: 1 filed by Galentic Pharma India, 4 filed against it. 4 cases are pending and 1 is disposed.
Total cases
5
Filed by the company
1
Filed against the company
4
Pending
4
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 4 | 4 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Commercial suit | Filed by the company against Bhavin Containers Private Limited | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Commercial matter | Filed against the company by an individual | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Interim or miscellaneous application | Filed against the company by an individual | Pending |
| District court, kachchh at Bhuj, Gujarat | Court case (PWAPP LC) | Filed against the company by an individual | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (SUMMONS CASES SS) | Filed against the company by an individual | Disposed |
To see the full case history of Galentic Pharma India Pvt Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Galentic Pharma India Pvt Ltd has 4 MSME Form 1 returns on record between 2018 and 2020, listing 4 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Fabtech Technologies International Private Limited |
To see the full MSME payment records of Galentic Pharma India Pvt Ltd, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Galentic Pharma India has 1 subsidiary company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| The Ethical Pharmaceutical Co. Private Limited | U24200MH1981PTC025411 |
To see the full group structure of Galentic Pharma India Pvt Ltd, buy the company report.
Employees & EPFO
Galentic Pharma India Pvt Ltd has a workforce of 294 employees on its EPFO records as of Mar 08, 2025, across 1 active EPFO establishment.
Employee count
294
Active EPFO establishments
1
Employee growth
10.11%
GST
Galentic Pharma India has 3 GST registrations: 3 active.
Total GSTINs
3
Active
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACG2390L1ZG | Maharashtra | Active | 01 Jul 2017 |
| 27AAACG2390L2ZF | Maharashtra | Active | 15 May 2025 |
| 24AAACG2390L1ZM | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Galentic Pharma India Pvt Ltd, buy the company report.
Recent activity
Galentic Pharma India Pvt Ltd has 15 board changes on record since 1994: 7 appointments and 8 cessations. The latest: Jay Narendra Mehta ceased to be Additional Director on 30 Sep 2022.
Charges
A charge with Hdfc Bank Limited of Rs. 6,820.00 Lakh registered on 30 Sep 2013 with Charge ID 10454461 was modified on 14 Oct 2025.
AGM
Galentic Pharma India Pvt Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 32.40 Lakh with Charge ID 101100210 was registered on 28 Apr 2025.
Filing
Galentic Pharma India Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Hdfc Bank Limited of Rs. 1,100.00 Lakh registered on 11 Oct 2013 with Charge ID 10454464 was modified on 18 Dec 2023.
Charges
A charge with Hdfc Bank Limited of Rs. 1,100.00 Lakh registered on 26 Apr 2008 with Charge ID 10103782 was modified on 18 Dec 2023.
Ceased
Jay Narendra Mehta ceased to be Additional Director.
Charges
A charge with Citi Bank N.A. amounted to Rs. 720.00 Lakh with Charge ID 100546148 was registered on 25 Feb 2022.
Charges
A charge with Citi Bank N.A. amounted to Rs. 1,500.00 Lakh with Charge ID 100527285 was registered on 21 Jan 2022.
Appointed
Amisha Maulin Gandhi was appointed as Director.
Appointed
Jay Narendra Mehta was appointed as Director.
Appointed
Manthan Kamlesh Vohra was appointed as Director.
20 earlier events are in the company report.
Frequently asked questions
Galentic Pharma India is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 March 1992 (34+ years old) and is registered under CIN U24230MH1992PTC065825.
Galentic Pharma India has 7 current directors:
- Bhupendra Harkisandas Sangani - Managing Director
- Smita Bhupendra Sangani - Director
- Amisha Maulin Gandhi - Director
- Manthan Kamlesh Vohra - Director
- Jay Narendra Mehta - Director
- Hemang Kamlesh Vohra - Director
- Kamlesh Satyendra Vohra - Director
The latest financial statements of Galentic Pharma India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Galentic Pharma India is 27AAACG2390L1ZG, registered in Maharashtra. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 27AAACG2390L2ZF (Maharashtra), 24AAACG2390L1ZM (Gujarat).
The CIN (Corporate Identification Number) of Galentic Pharma India is U24230MH1992PTC065825. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Galentic Pharma India has 5 court cases on record: 1 filed by the company and 4 filed against it. 4 are pending.
Galentic Pharma India was incorporated on 10 March 1992, making it 34+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Galentic Pharma India by revenue are Alphamed Formulations Private Limited, Jagdale Industries Private Limited, Therachem Research Medilab (India) Private Limited, Sriram Healthcare Private Limited, Parnax Lab Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Jay Narendra Mehta ceased to be Additional Director on 30 Sep 2022. Amisha Maulin Gandhi was appointed as Director on 28 Sep 2021. Jay Narendra Mehta was appointed as Director on 28 Sep 2021. Galentic Pharma India has 15 board changes on record in total.
Yes, Galentic Pharma India is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-19-0027888).
Galentic Pharma India has 4 MSME Form 1 returns on record between 2018 and 2020, listing 4 overdue payments to 1 micro and small supplier. The latest return was filed on 29 Oct 2020.
Galentic Pharma India can be reached through the website galentic.com. Its registered office is in Mumbai, Maharashtra, India.